Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03409484 · ClinicalTrials.gov registry record · NA
Effects of Concord Grape Juice Alone on Glycemia, Appetite and Cognitive Function in Healthy Adults
A NA study of Appetitive Behavior and Glycemic Response, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT03409484: Completed NA study of Appetitive Behavior and Glycemic Response, sponsored by Purdue University.
NCT03409484 is a NA study of Appetitive Behavior and Glycemic Response that has completed, run by Purdue University. The registered enrollment target is 40 participants, below the 54-participant average among 11 other Appetitive Behavior trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03409484, a NA study of Appetitive Behavior and Glycemic Response, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Assess the impact of 100% grape juice on postprandial glycemic response and subsequent appetite, food intake and cognitive function.
Primary Outcome
samples taken every 5 minutes for 24 hours by a continuous glucose monitor
Conditions Studied
Interventions
- OTHER Concord Grape Juice
- OTHER Low flavoniod low essence beverage
- OTHER Low flavonoid beverage
Study Locations (1)
Indiana
- Purdue University - West Lafayette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-10-10 |
| Est. Completion | 2019-09-20 |
| Phase | NA |
What the finished NCT03409484 record still lists
NCT03409484 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 54-participant average among 11 other Appetitive Behavior trials with a reported enrollment target (26% lower).
The record links to 2 conditions, with Appetitive Behavior appearing as the primary indexed condition, and to 3 interventions - of which Concord Grape Juice is the first listed.
NCT03409484 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT03409484 about?
NCT03409484 is a clinical study titled "Effects of Concord Grape Juice Alone on Glycemia, Appetite and Cognitive Function in Healthy Adults". Assess the impact of 100% grape juice on postprandial glycemic response and subsequent appetite, food intake and cognitive function.
What is the current status of trial NCT03409484?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-10-10. Estimated completion is 2019-09-20.
What conditions does trial NCT03409484 study?
This clinical trial studies the following conditions: Appetitive Behavior, Glycemic Response.
What interventions are being tested in trial NCT03409484?
The interventions under investigation include: Concord Grape Juice (OTHER), Low flavoniod low essence beverage (OTHER), Low flavonoid beverage (OTHER).
Who is sponsoring clinical trial NCT03409484?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03409484 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Appetitive Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03409484's enrollment target sits among peer trials
40 4th of 11 higher than 7 of 11 other Appetitive Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Appetitive Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Food for Thought: Executive Functioning Around Eating Among Children
RECRUITING · NA
-
Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans
RECRUITING · NA
-
Exercise, Brain Activity, and Weight Maintenance
RECRUITING · NA
-
SATISFY (geleSis100 Effects on AppeTIte Sensations, Feeding Behavior and Dietary energY)
COMPLETED · NA
-
Whole Grains, Gastric Emptying and Glycemic Response
COMPLETED · NA
-
Barley Beta-glucan, Glycemic Control, and Appetite
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI